SCHEMBL1117822

SCHEMBL1117822

O=C(O)N1C=CC=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8221742 0.98
SCHEMBL2801118 0.79
Water SCHEMBL7805742 0.77
SCHEMBL11098112 0.73
SCHEMBL27457961 0.70 FAAH (0.34)
SCHEMBL8397757 0.67
SCHEMBL6638438 0.67
SCHEMBL4075430 0.67 HTT (0.39)
SCHEMBL7342409 0.67 RAB9A (0.30)
SCHEMBL7339156 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2537534-B1 Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use. HEXAL AG (DE) 2014-12-17 EP claimed
EP-1073673-A1 NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS HOECHST MARION ROUSSEL (FR) 2001-02-07 EP claimed
WO-1999055724-A1 NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS HOECHST MARION ROUSSEL (FR) 1999-11-04 WO claimed
US-5723602-A ANGIOTENSIN CONVERTING ENZYME AND ENDOPEPTIDASE INHIBITORS, CARDIOVASCULAR DISORDERS E. R. SQUIBB & SONS, INC. (US) 1998-03-03 US claimed
EP-0100906-A2 Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-02-22 EP claimed
US-6433164-B1 None US disclosed
CN-117263959-A Preparation and application of aromatic KRAS mutant protein inhibitor 药雅科技(上海)有限公司 2023-12-22 CN disclosed
CN-112513049-B Heterocyclic compounds and their use in the prevention or treatment of bacterial infections 拜欧蒂姆公司 2023-11-28 CN disclosed
CN-113906028-A Fused heterocyclic derivatives 爱尔兰詹森科学公司 2022-01-07 CN disclosed
CN-113891889-A Diazepinone derivatives as capsid assembly modulators 爱尔兰詹森科学公司 2022-01-04 CN disclosed
CN-109311908-B Dihydropyrazole azepinoids as Akt inhibitors 哈尔滨珍宝制药有限公司 2021-05-07 CN disclosed
US-10975077-B2 Diazepinone derivatives and their use in the treatment of hepatitis B infections NOVIRA THERAPEUTICS, INC. (US) 2021-04-13 US disclosed
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 EP disclosed
EP-0783002-A2 Dual action inhibitors E.R. SQUIBB & SONS, INC. (US) 1997-07-09 EP disclosed
WO-1997022619-A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-06-26 WO disclosed
US-5552397-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1996-09-03 US disclosed
WO-1996015129-A1 OXAZOLYL- AND THIAZOLYLIMIDAZO-BENZO- AND THIENODIAZEPINES AND THEIR USE AS MEDICAMENTS F. HOFFMANN-LA ROCHE AG (CH) 1996-05-23 WO disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 WO disclosed
EP-0100906-B1 TRI- AND TETRACYCLIC IMIDAZO(1,5-A)(1,4)BENZODIAZEPIN-1-CARBOXYLIC-ACID DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-05-13 EP disclosed
EP-0094095-A2 Bicyclic carboxylic acids and their alkyl and aralkyl esters F. HOFFMANN-LA ROCHE AG (CH) 1983-11-16 EP disclosed